FAAH and Anxiety: Specifically, inhibition of the eCB‐degrading enzyme FAAH has been successfully tested in animal models for inflammation, chronic pain, and anxiety, without remarkable adverse effects (Kathuria et al, 2003; Russo et al, 2007; Ahn et al, 2009).